Tirzepatide 15mg

Chemical Name: Tirzepatide
Molecular Formula: C225H348N48O68
Molecular Weight: 4813.48 g/mol
CAS Number: 2023788-19-2
Synonyms: Mounjaro
Therapeutic Category: Antidiabetic Agent, Dual GIP and GLP-1 Receptor Agonist
Form: Lyophilized (Freeze-Dried) Powder
Storage Conditions: Store in a freezer at -20°C. Avoid repeated freeze-thaw cycles.
Package Contents: Vials containing lyophilized powder.
Availability: For research and medical use

Product Description

Tirzepatide is a novel, synthetic peptide with dual agonist activity at the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. Its unique mechanism of action leverages the complementary effects of GLP-1 and GIP to enhance glycemic control more effectively than GLP-1 receptor agonism alone. Tirzepatide promotes glucose-dependent insulin secretion, suppresses glucagon secretion, slows gastric emptying, and also reduces food intake through appetite regulation. These actions contribute to significant improvements in glycemic control and weight loss in individuals with type 2 diabetes.